Drug trial offers hope for patients with hard-to-treat lung cancer in China, US
lung cancer , according to an international clinical trial led by Chinese and US scientists.
Advertisement
The findings were published in the New England Journal of Medicine (NEJM) on April 28 and presented at the American Association for Cancer Research Annual Meeting in Chicago on the same day.
The researchers found that the oral medication zongertinib outperformed the standard treatment option when treating HER2-mutated non-small cell lung cancer (NSCLC). It works by targeting the HER2 protein and blocking the activity of the protein's tyrosine kinase, which is responsible for signalling cell growth.
This type of lung cancer is particularly difficult to treat. Unlike other NSCLC variants, it only has one treatment option that has been approved by the US Food and Drug Administration: intravenous antibody-drug conjugate (ADC) therapy. And ADC-class medications carry risks of adverse effects, including diarrhoea, nausea, fatigue and skin rashes.
Wang Xin, professor at the Chinese Academy of Medical Sciences Cancer Hospital, said in an April 29 review of the NEJM study that zongertinib had the 'potential to establish a new benchmark for targeted therapy in HER2-mutant NSCLC'.
10:51
New oral treatment for blood cancer offers 97% cure rate, Hong Kong researchers say
New oral treatment for blood cancer offers 97% cure rate, Hong Kong researchers say
The multi-cohort study was conducted at 82 sites around the world, including 18 US institutions, 17 in China and three in Japan. The analysis published by the NEJM included 188 NSCLC patients, with Asian populations accounting for a majority.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
14 hours ago
- South China Morning Post
China's new stealth launcher is aimed at space debris. Can it also be used as a weapon?
Chinese scientists have unveiled a projectile launcher for use in space – a device designed to remove dangerous debris orbiting the Earth but with potential to also be used as a weapon. The compact and stealthy device draws on the principle of gunpowder propulsion dating back to 9th century China, but brings it into the new space age It was jointly developed by aerospace engineers in Nanjing, Shanghai and Shenyang and unveiled last month in the peer-reviewed Chinese journal Acta Aeronautica et Astronautica Sinica. The projectile launcher (left) was designed to tackle the growing problem of orbital debris. Photo: Nanjing University of Science and Technology Unlike conventional guns that can produce blinding flashes, intense vibrations and clouds of debris, the new device creates no smoke, no light and little vibration when fired, according to the paper. This is achieved through a closed-gas, energy-absorbing mechanism. That means a capsule – containing a net for capturing debris – can be precisely launched towards its target without any harmful jolt to the launch platform, said the team led by Yue Shuai, associate professor of mechanical engineering at Nanjing University of Science and Technology. When the launcher is fired, a small charge ignites that generates high-pressure gas which drives a piston forward. A specially designed weak section then breaks at a predetermined pressure, releasing the projectile. A ring angled at 35 degrees meets the projectile near the muzzle, taking most of the kinetic energy and vibration to bend like a flower collapsing inwards.
South China Morning Post
15 hours ago
- South China Morning Post
Hong Kong biotech firm races to develop chikungunya fever test for early detection
Hong Kong is developing a rapid test for chikungunya fever that could detect the disease at an earlier stage, as part of the city's efforts to harness technology to combat the public health risk. Advertisement Ricky Chiu Yin-to, founder and CEO of biotechnology company Phase Scientific, said on Monday that his team was working to develop a rapid blood test that could yield results in 10 to 15 minutes by finger pricking. The test being developed in Hong Kong aims to detect the antigen, specific proteins on the surface of the chikungunya virus, instead of looking for antibodies produced by the body – an approach adopted by many other rapid tests in the world. 'When you are at the stage of acute infection, the test could identify chikungunya virus from your blood, instead of looking into a more secondary immune response of your body,' Chiu said. The existing rapid test kits for chikungunya fever available in the market, produced by companies including those from the United States and mainland China, look for the virus antibodies that are produced at a later stage of infection. Advertisement But Chiu said there could be shortcomings with test kits looking for antibodies.
South China Morning Post
19 hours ago
- South China Morning Post
Health checks on older Hong Kong taxi drivers should be ‘targeted': experts
Compulsory health checks on older taxi drivers in Hong Kong to evaluate their capacity to drive should be targeted to cover cabbies' cognitive abilities and take into account their medications, with clearer guidelines on specific conditions, industry experts have said. Advertisement Ringo Lee Yiu-pui, honorary life president of the Hong Kong, China Automobile Association, said on Monday that more regular health screenings for drivers aged 65 or above should be conducted, with specific and comprehensive tests, before they could renew their licences. 'We could introduce cognitive assessments because seniors might be weaker in their cognitive abilities for driving,' Lee told a radio programme, adding that those who only passed a physical examination might not necessarily be fit to drive long hours professionally. Hong Kong authorities have faced renewed calls for stricter health checks on older cabbies after a Filipino tourist was killed last week by a speeding taxi driven by an 80-year-old. On Saturday, Secretary for Transport and Logistics Mable Chan pledged to tighten requirements through legislation no later than the first quarter of next year Advertisement Under current regulations, only those aged 70 or older are required to submit health reports, while their driving licences can be renewed for up to three years. The fitness certification covers aspects such as the driver's eyesight and hearing, skeletal and muscular system, balance and coordination, and mental state, among others.
